BRIEF published on 05/12/2025 at 15:53, 1 year ago The Vanguard Group's Position in Qualcomm: Disclosure Details Form 8.3 Takeover Code Vanguard Group Shareholding Qualcomm
BRIEF published on 05/12/2025 at 15:50, 1 year ago The Vanguard Group Discloses Significant Position in American Axle & Manufacturing Takeover Code Vanguard Group Stock Disclosure Equity Holdings American Axle
PRESS RELEASE published on 05/12/2025 at 15:48, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses a 10.56% interest in Qualcomm Incorporated. Details of position, dealings, and disclosures under Form 8.3 Securities Form 8.3 Disclosure Vanguard Group Qualcomm
PRESS RELEASE published on 05/12/2025 at 15:45, 1 year ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 10.95% interest in American Axle & Manufacturing Holdings, Inc. through Form 8.3 filing on 12-May-2025 Form 8.3 Vanguard Group American Axle 10.95% Interest Filing Disclosure
BRIEF published on 05/12/2025 at 15:45, 1 year ago The Vanguard Group, Inc. Discloses Position in Aviva plc Form 8.3 Takeover Code Vanguard Group Direct Line Insurance Aviva Plc
PRESS RELEASE published on 05/12/2025 at 15:40, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Aviva plc The Vanguard Group, Inc. discloses a 5.18% ownership in Aviva plc as of 09 May 2025. Details of acquisitions and interests in relevant securities Relevant Securities The Vanguard Group Ownership Disclosure Ownership Percentage Aviva Plc
BRIEF published on 05/09/2025 at 16:09, 1 year ago The Vanguard Group, Inc. Discloses Significant Shareholding in Qualcomm Form 8.3 Takeover Code Vanguard Group Shareholding Disclosure Qualcomm Shares
BRIEF published on 05/09/2025 at 16:09, 1 year ago The Vanguard Group Discloses Stake in American Axle & Manufacturing Holdings Securities Form 8.3 Disclosure The Vanguard Group American Axle
BRIEF published on 05/09/2025 at 16:08, 1 year ago The Vanguard Group Reports Stake in Dalata Hotel Group Securities Form 8.3 Disclosure The Vanguard Group Dalata Hotel Group
BRIEF published on 05/09/2025 at 16:07, 1 year ago The Vanguard Group Discloses Stake in Mural Oncology plc Ordinary Shares Irish Takeover Panel Vanguard Group Stake Disclosure Mural Oncology
Published on 05/30/2026 at 04:00, 2 days 2 hours ago Vanta Announces Strategic Private Placement Financing to Advance U.S. Peptide Market Entry and Integrated Longevity and Consumer Health Sciences Platform
Published on 05/30/2026 at 02:40, 2 days 4 hours ago BEACN Announces Financial Results for the First Quarter of 2026 and Update on Loan
Published on 05/30/2026 at 01:30, 2 days 5 hours ago Core Critical Approved for Listing on OTCQB(R) Venture Market
Published on 05/30/2026 at 00:31, 2 days 6 hours ago Gold Basin Resources Provides Updates on Arrangement with CANEX
Published on 05/29/2026 at 23:00, 2 days 7 hours ago The Fresh Factory Reports Q1 2026 Financial Results with 17% Billed Revenue Growth, Completes New Facility Retrofit
Published on 06/01/2026 at 06:15, 41 minutes ago Embracing a Zero-Carbon Future | The 6th LiuGong Global Customer Day Held in Liuzhou
Published on 05/31/2026 at 00:15, 1 day 6 hours ago Take Your Shot & Make Your Moment: OPPO Ignites Football Culture with Technology at the UEFA Champions League Final
Published on 05/30/2026 at 19:35, 1 day 11 hours ago THE KILLERS ROCK THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®
Published on 05/30/2026 at 17:10, 1 day 13 hours ago MakerWorld's First User-Initiated Charity Contest Names Winners, Bringing Global Creators' Goodwill Directly to Cancer Wards
Published on 05/29/2026 at 22:00, 2 days 8 hours ago Information on the Annual Financial Statements 2025
Published on 05/29/2026 at 18:00, 2 days 12 hours ago Recticel Group acquires Isopanel NV to deliver integrated solutions in the cold storage panels market
Published on 05/29/2026 at 12:00, 2 days 18 hours ago Capital increase through exercise of subscription rights
Published on 05/29/2026 at 10:30, 2 days 20 hours ago bioMérieux invests in France with a new facility to produce innovative diagnostics for the European market
